About AdoptFly
We only help a provider use something new if we'd prescribe it to our own patients.
Our mission is to help providers improve patient outcomes with innovations they can trust.
Holding that rule for 16 years is why 95% of the providers we work with stay, and most of our clients come to us by referral.
The rule
We treat every innovation as a prescription we'd have to write.
A clinician doesn't reach for a treatment because it's new. They match the right solution to a real problem, backed by evidence, and only if it's safe for the patient in front of them. We hold every new technology to that same test, whatever it is: a device, a diagnostic, a wound treatment, a piece of software. We find the real problem it solves, and put it through the same three questions a clinician asks before writing a prescription:
Is it right for this patient?
The right problem, and the right patient for it.
Is it safe?
Safe enough to use on our own patients.
Will it truly help?
A real difference the patient will feel.
If we wouldn't prescribe it ourselves, we won't ask a provider to.
What we are, what we're not
We back what we'd prescribe. Nothing we wouldn't.
AdoptFly is
AdoptFly is not
We work with FDA-cleared technologies across therapeutic areas.
Founder
Dr. Adam Read
Adam is a physician-technologist. 16 years across clinical medicine, quality improvement, and health technology.
The rule comes from him: a clinician who won't prescribe without proof, holding every new technology to that same bar.
Building a real-world outcomes network across 268,000 patients showed him the truth behind it. The gap between a good idea and real adoption is a design problem, not a data one.
It's personal. Adam's brother died abroad after two hospitals couldn't move his medical records in time. The records existed. The way to move them didn't.
Since, he has supported more than 250,000 providers across 35 countries, launched three world-first innovations, and held a 95% provider engagement rate across every structured program.